GlassScriptPhysician profile
Andrew S Walker
NPI 1144332396
$14,561.99
in general payments reported to CMS, 2019-2025
10 companies · $1,566 in 2025
The $1,566 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.01 · 2020: $18.67 · 2021: $7,313 · 2022: $4,245 · 2023: $113 · 2024: $1,287 · 2025: $1,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,526 · Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,526.10 |
| Food and Beverage | $1,440.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,796.01 | 2021-2025 | Da Vinci Surgical System |
| Davol INC. | $526.34 | 2024-2025 | Phasix Mesh |
| Tela Bio, INC. | $56.88 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $52.81 | 2025 | Vistaseal |
| Acell, INC. | $37.68 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $24.58 | 2023 | Seglentis |
| Integra Lifesciences Corporation | $22.00 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $16.59 | 2024 | |
| Idorsia Pharmaceuticals US INC | $15.60 | 2024 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.50 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.